HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
14.70
+0.39 (2.73%)
Oct 6, 2026, 4:00 PM EDT - Market closed
HUTCHMED (China) Market Cap
HUTCHMED (China) has a market cap or net worth of $2.61 billion as of October 6, 2026. Its market cap has decreased by -6.13% in one year.
Market Cap
2.61B
Enterprise Value
1.34B
1-Year Change
-6.13%
Ranking
Category
Stock Price
$14.70
ChartMarket Cap Chart
Since March 17, 2016, HUTCHMED (China)'s market cap has increased from $1.60B to $2.61B, an increase of 63.62%. That is a compound annual growth rate of 4.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 2.48B | 6.55% |
| Dec 31, 2025 | 2.33B | -7.42% |
| Dec 31, 2024 | 2.51B | -19.95% |
| Dec 29, 2023 | 3.14B | 22.75% |
| Dec 30, 2022 | 2.56B | -50.05% |
| Dec 31, 2021 | 5.12B | 19.79% |
| Dec 31, 2020 | 4.27B | 27.79% |
| Dec 31, 2019 | 3.34B | 8.92% |
| Dec 31, 2018 | 3.07B | -35.89% |
| Dec 29, 2017 | 4.79B | 195.91% |
| Dec 30, 2016 | 1.62B | 1.27% |
| Mar 17, 2016 | 1.60B | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Regencell Bioscience Holdings | 3.53B |
| Amylyx Pharmaceuticals | 3.44B |
| Supernus Pharmaceuticals | 2.42B |
| Liquidia | 2.34B |
| Bausch Health Companies | 2.23B |
| Prestige Consumer Healthcare | 2.19B |
| Alvotech | 2.17B |
| Trulieve Cannabis | 2.05B |